Neurocritical Care

, Volume 18, Issue 2, pp 193–200

Treatment of Status Epilepticus: An International Survey of Experts

  • James J. RivielloJr.
  • Jan Claassen
  • Suzette M. LaRoche
  • Michael R. Sperling
  • Brian Alldredge
  • Thomas P. Bleck
  • Tracy Glauser
  • Lori Shutter
  • David M. Treiman
  • Paul M. Vespa
  • Rodney Bell
  • Gretchen M. Brophy
  • The Neurocritical Care Society Status Epilepticus Guideline Writing Committee
Original Article

Abstract

Background

As part of the development of the Neurocritical Care Society (NCS) Status Epilepticus (SE) Guidelines, the NCS SE Writing Committee conducted an international survey of SE experts.

Methods

The survey consisted of three patient vignettes (case 1, an adult; case 2, an adolescent; case 3, a child) and questions regarding treatment. The questions for each case focused on initial and sequential therapy as well as when to use continuous intravenous (cIV) therapy and for what duration. Responses were obtained from 60/120 (50%) of those surveyed.

Results

This survey reveals that there is expert consensus for using intravenous lorazepam for the emergent (first-line) therapy of SE in children and adults. For urgent (second-line) therapy, the most common agents chosen were phenytoin/fosphenytoin, valproate sodium, and levetiracetam; these choices varied by the patient age in the case scenarios. Physicians who care for adult patients chose cIV therapy for RSE, especially midazolam and propofol, rather than a standard AED sooner than those who care for children; and in children, there is a reluctance to choose propofol. Pentobarbital was chosen later in the therapy for all ages.

Conclusion

There is close agreement between the recently published NCS guideline for SE and this survey of experts in the treatment of SE.

Keywords

Status epilepticus Seizure Survey Antiepileptic treatment 

References

  1. 1.
    Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120–2.PubMedCrossRefGoogle Scholar
  2. 2.
    Brophy GB, Bell R, Alldredge A, Bleck TP, Claassen J, LaRoche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.Google Scholar
  3. 3.
    Bleck TP. Refractory status epilepticus. Curr Opin Crit Care. 2005;11(2):117–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics. 2002;110(6):1177–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Kinoshita H, Nakagawa E, Iwasaki Y, Hanaoka S, Sugai K. Pentobarbital therapy for status epilepticus in children: timing of tapering. Pediatr Neurol. 1995;13(2):164–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Holtkamp M, Othman J, Buchheim K, Meierkord M. Predictors and prognosis for refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Sakuma H. Acute encephalitis with refractory, repetitive partial seizures. Brain Dev. 2009;31(7):510–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Sahin M, Menache C, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42(11):1461–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of acute symptomatic refractory status epilepticus in children. Neurology. 2003;61(3):398–401.PubMedCrossRefGoogle Scholar
  11. 11.
    Kramer U, Shorer Z, Ben-Zeev B, Lerman-Sagie T, Goldberg-Stern H, Lahat E. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol. 2005;20(3):184–7.PubMedGoogle Scholar
  12. 12.
    Mikaeloff Y, Jambaque I, Hertz-Pannier L, Zamfirescu A, Adamsbaum C, Plouin P, Dulac O, Chiron C. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res. 2006;69(1):67–79.PubMedCrossRefGoogle Scholar
  13. 13.
    Baxter P, Clarke A, Cross H, Harding B, Hicks E, Livingston J, Surtees R. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure. 2003;12(6):379–87.PubMedCrossRefGoogle Scholar
  14. 14.
    Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, Ong BK. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore. 2005;34(7):417–20.PubMedGoogle Scholar
  15. 15.
    van Baalen A, Hausler M, Boor R, Rohr A, Sperner J, Kurlemann G, Panzer A, Stephani U, Kluger G. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51(7):1323–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, Nabbout R, Kluger G, Lin JJ, van Baalen A. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • James J. RivielloJr.
    • 1
  • Jan Claassen
    • 2
  • Suzette M. LaRoche
    • 3
  • Michael R. Sperling
    • 4
  • Brian Alldredge
    • 5
  • Thomas P. Bleck
    • 6
  • Tracy Glauser
    • 7
  • Lori Shutter
    • 8
  • David M. Treiman
    • 9
  • Paul M. Vespa
    • 10
  • Rodney Bell
    • 4
  • Gretchen M. Brophy
    • 11
  • The Neurocritical Care Society Status Epilepticus Guideline Writing Committee
  1. 1.NYU Comprehensive Epilepsy Center, NYU Langone Medical Center, Division of Pediatric Neurology, Department of NeurologyNew York University School of MedicineNew YorkUSA
  2. 2.Columbia UniversityNew YorkUSA
  3. 3.Emory UniversityAltantaUSA
  4. 4.Thomas Jefferson UniversityPhiladelphiaUSA
  5. 5.University of CaliforniaSan FranciscoUSA
  6. 6.Rush University Medical CenterChicagoUSA
  7. 7.Cincinnati Children’s Hospital Medical CenterCincinnatiUSA
  8. 8.University of Cincinnati Medical CenterCincinnatiUSA
  9. 9.Arizona State UniversityTempeUSA
  10. 10.University of CaliforniaLos AngelesUSA
  11. 11.Virginia Commonwealth UniversityRichmondUSA

Personalised recommendations